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AbsTrACT
Objective Limbic encephalitis associated with 
antibodies to components of the voltage-gated 
potassium channel complex (VGKcc-ab-Le) often 
leads to hippocampal atrophy and persistent memory 
impairment. Its long-term impact on regions beyond 
the hippocampus, and the relationship between brain 
damage and cognitive outcome, are poorly understood. 
We investigated the nature of structural and functional 
brain abnormalities following VGKcc-ab-Le and its role 
in residual memory impairment.
Method a cross-sectional group study was conducted. 
Twenty-four VGKcc-ab-Le patients (20 male, 4 female; 
mean (sD) age 63.86 (11.31) years) were recruited 
post-acutely along with age- and sex-matched healthy 
controls for neuropsychological assessment, structural 
MRI and resting-state functional MRI (rs-fMRI). structural 
abnormalities were determined using volumetry and 
voxel-based morphometry; rs-fMRI data were analysed 
to investigate hippocampal functional connectivity (Fc). 
associations of memory performance with neuroimaging 
measures were examined.
results patients showed selective memory impairment. 
structural analyses revealed focal hippocampal 
atrophy within the medial temporal lobes, correlative 
atrophy in the mediodorsal thalamus, and additional 
volume reduction in the posteromedial cortex. There 
was no association between regional volumes and 
memory performance. Instead, patients demonstrated 
reduced posteromedial cortico-hippocampal and inter-
hippocampal Fc, which correlated with memory scores (r 
= 0.553; r = 0.582, respectively). The latter declined as a 
function of time since the acute illness (r = -0.531).
Conclusion VGKcc-ab-Le results in persistent isolated 
memory impairment. patients have hippocampal 
atrophy with further reduced mediodorsal thalamic and 
posteromedial cortical volumes. crucially, reduced Fc of 
remaining hippocampal tissue correlates more closely 
with memory function than does regional atrophy.
InTrOduCTIOn
Antibody-mediated limbic encephalitis (LE) is char-
acterised by the subacute onset of amnesia and 
seizures and is commonly associated with anti-
bodies against components of the voltage-gated 
potassium channel complex (VGKCC-Ab-LE): 
leucine-rich glioma-inactivated 1 (LGI1) and 
contactin-associated protein-like 2 (CASPR2).1 In 
the acute phase, MRI often reveals high T2 signal in 
the medial temporal lobes (MTL), a region crucial 
for memory processing.2 Although patients typi-
cally respond well to immunosuppressive therapy,3 
some develop MTL atrophy and persistent cogni-
tive impairment.4–6 In certain cohorts, 89% of 
patients develop hippocampal atrophy7 and 65% 
experience persistent memory deficits.8 The long-
term cognitive outcome of VGKCC-Ab-LE has been 
investigated in a small number of group studies.5 6 8 
These concur that memory impairment is the most 
salient feature, among other deficits.6
Nevertheless, the cognitive outcome in LE is diffi-
cult to predict and its relationship to brain damage 
poorly understood. Research so far has focused on 
the hippocampus, given that this is usually the locus 
of acute pathology, at least as detected on clinical 
MRI. Manual delineation of the hippocampus on 
MRI demonstrates atrophy following VGKCC-
Ab-LE.6 9 However, clinical experience suggests that 
memory function correlates poorly with focal struc-
tural damage following VGKCC-Ab-LE; patients 
with apparently normal imaging may complain of 
marked memory impairment and vice versa.
It is less clear whether other areas within broader 
networks (eg, hippocampal-thalamic-neocor-
tical10 11) are affected and contribute to residual 
memory impairment. Hippocampal damage in 
patients is also likely to disrupt functional connec-
tivity (FC) with other regions supporting episodic 
memory within the partially overlapping limbic 
circuitry (eg, thalamus, posterior cingulate12) and 
the default-mode network.13 Such abnormalities 
have been reported in other encephalitides14 and 
neurodegenerative conditions.15 In a recent explor-
atory study in VGKCC-Ab-LE, FC alterations in 
large-scale networks were correlated with memory 
function, independent of hippocampal volume.7 
Disrupted FC may thus be a better marker of 
amnesia in VGKCC-Ab-LE. Furthermore, under-
standing the impact of focal hippocampal damage 
on wider memory networks may inform under-
standing of cognitive deficits in other neurolog-
ical diseases, as well as the neuroscience of human 
memory, since LE patients are often used as ‘lesion 
models’ to investigate hippocampal function.16 17
We thus investigated the neural correlates of 
long-term cognitive outcome in VGKCC-Ab-LE, in 
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Figure 1 Grey matter volume reduction in the hippocampus, thalamus, 
and posteromedial cortex in VGKcc-ab-Le patients. (a) T1-weighted MRI 
scans of an example control (left) and patient (right) with corresponding 
3D rendering of manual segmentation masks. (B) Graph depicting total 
hippocampal volumes for patients (z-scores calculated on the basis of mean 
and sD of TIV-corrected volumes of individually age-matched controls). (c) 
hippocampal and thalamic volumes correlated strongly across patients. 
Dashed lines indicate that there was no thalamic atrophy (z<−1.5) in 
the absence of hippocampal atrophy. (D) VBM maps overlaid on sagittal 
sections of DaRTeL GM template in MNI space display bilaterally reduced 
GM volume in patients compared with controls (over and above age, sex, 
and TIV) in the hippocampus, thalamus, and precuneus-posterior cingulate. 
clusters survive correction for non-stationary smoothness and FWe 
(p<0.05) across the whole brain for cluster size over p<0.001 (smoothing 
kernel: 8 mm FWhM). heat bar indicates t-scores. FWe, family-wise error; 
FWhM, full width at half maximum; GM, grey matter; hpc, hippocampus; 
MNI, Montreal Neurological Institute; TIV, total intracranial volume; VBM, 
voxel-based morphometry; VGKcc-ab-LΕ, limbic encephalitis associated 
with antibodies to components of the voltage-gated potassium channel 
complex.
particular the possibility that memory function is determined to a 
greater extent by reduced hippocampal FC than by hippocampal 
atrophy. Using clinical assessment, cognitive evaluation, and 
structural and functional neuroimaging, we examined evidence 
of (1) extra-hippocampal structural damage, (2) reduced FC, and 
(3) a role of such disruptions in residual memory impairment 
following VGKCC-Ab-LE.
MeThOds
subjects
Twenty-four patients were recruited into the University of 
Oxford’s Memory and Amnesia Project (MAP). Patients were 
identified from neurology clinics within UK NHS Trusts, 
presented with clinical features typical of LE,2 tested positive for 
serum VGKCC antibodies, reported persistent memory difficul-
ties, and had no pre-existing neurological or psychiatric illness. 
All patients (20 male, 4 female) were in the post-acute phase 
(mean (SD) 5.22 (3.77) years) and came to Oxford for clinical 
assessment, neuropsychological testing, structural MRI, and 
resting state functional MRI (rs-fMRI).
Healthy controls were recruited (1) through local advertise-
ment (n=39, of whom all underwent neuropsychology and 33 
underwent structural and rs-fMRI) and (2) through the Oxford 
Project To Investigate Memory and Ageing (n=32; structural 
MRI only). Patients (mean (SD) age 63.86 (11.31) years) and 
controls (mean (SD) age 62.36 (12.09) years) were matched for 
age (t=−0.53, p=0.60), and were all fluent speakers of English.
Clinical evaluation
Clinical assessment included evaluation of medical records for 
details of presentation onset, subsequent investigations, and 
response to treatment. Patients were invited for a research-ori-
ented clinical appointment with a consultant neurologist (CRB) 
for detailed medical history and evaluation of ongoing clinical 
and cognitive problems.
Antibody testing
Patient serum samples were tested for VGKCC antibodies from 
125I-adendrotoxin labelled rabbit brain extract by routine 
immunoprecipitation.2 Cell-based assays for LGI1, CASPR2 and 
contactin-2 Abs used human embryonic kidney 293 cells trans-
fected with DNAs encoding membrane-anchored LGI1, CASPR2 
or contactin-2, which were incubated with sera.1
neuropsychological assessment
Neuropsychological tests were administered to assess premorbid 
intelligence, semantic memory and language, episodic memory, 
executive function, visuospatial/motor function and mood 
(online supplementary table S1). The p values were adjusted 
(‘p-corr’) using the Holm-Bonferroni sequential correction for 
multiple comparisons across all tests.
An overall composite memory score was derived from memory 
tests in which patients showed impaired performance at group 
level as compared with controls (p-corr <0.05), by averaging 
the age-scaled, standardised scores across these tests. Composite 
subscores were also formed separately for verbal/visual recall/
recognition memory.
Acute clinical MrI ratings
A consultant neuroradiologist graded signal intensity, volume, 
and diffusion of left and right hippocampi in the acute 
T2-weighted clinical MRIs (online supplementary material S1). 
Abnormalities outside these structures were noted.
scanning procedures
We acquired 3D T1-weighted structural MRIs and resting-state 
Blood Oxygenation Level Dependent (BOLD)-weighted fMRI 
data (online supplementary material S2).
Volumetry
Automated segmentation was conducted for the brainstem, 
thalamus, caudate nucleus, putamen and pallidum, using FSL 
FIRST (v. 6.0 http://www. fmrib. ox. ac. uk/ fsl18). For MTL struc-
tures (hippocampal head, body, tail; amygdala; perirhinal, 
entorhinal, parahippocampal cortices), since automated segmen-
tation methods are less reliable in the presence of pathology, we 
used manual segmentation, which remains the gold standard for 
hippocampal volumetric measurements19 (24/24 patients; 46/65 
controls) (figure 1A). Volumes were corrected for total intra-
cranial volume (TIV) and expressed for each patient as z-scores 
based on the mean volumes and SDs of individually age-matched 
controls (online supplementary material S3).
In order to investigate the relationship between MTL/subcor-
tical atrophy and memory impairment, atrophic volumes were 
entered in bivariate correlation analyses with composite memory 
scores. In order additionally to address the possibility that bilat-
erality of hippocampal atrophy, rather than overall volume 
loss, was associated with memory outcome, we trichotomised 
our patient group according to atrophy, using a traditional 
cut-off point of z<−1.5 SD below controls’ mean (eg, Gale and 
Hopkins20): the three subgroups comprised patients with bilat-
eral (left and right hippocampal volumes z<−1.5 SD), unilat-
eral (only left or right hippocampal volume z<−1.5 SD), or 
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no atrophy (left and right hippocampal volumes z>−1.5 SD). 
We subsequently compared these subgroups on their composite 
memory scores.
Voxel-based morphometry
To identify grey matter (GM) volume discrepancies between 
the control and patient groups at a whole-brain level, the 
T1-weighted images were analysed with VBM (online supple-
mentary material S4), and the average volumes expressed in the 
clusters disclosed by the VBM contrasts were entered in bivar-
iate correlation analyses with composite memory scores across 
patients. We also addressed the possibility that correlation of 
memory impairment with reduced volume may be a function of 
the spatial specificity of these clusters. Correlations were thus 
conducted separately at different levels of FWE (family-wise 
error)-correction (peak-/cluster-level) and image smoothing (4/8 
mm FWHM (full width at half maximum)), and were corrected 
for multiple comparisons separately at each level.
Functional connectivity analysis
Functional MRI data were preprocessed according to a default 
pipeline (online supplementary material S5) and were submitted 
to a series of FC analyses.
1. Multivariate pattern analysis: In order to identify seed re-
gions for post-hoc seed-to-voxel FC analyses in an unbiased, 
data-driven fashion, we used multivariate pattern analysis 
(MVPA) (contrast: controls<>patients; covariates: age, sex; 
Online supplementary material S6).
2. Seed-to-voxel whole-brain FC analysis: We seeded from re-
gions identified from the MVPA to explore FC between these 
regions and the rest of the brain. FC analyses (contrast: con-
trols<>patients; covariates: age, sex) involved thresholding 
of FC maps at a voxel level of p<0.001 and FWE-corrected 
(p<0.05) at cluster- or peak-level.
3. Region of interest (ROI)-to-ROI FC analysis: In order to in-
vestigate the FC of regions identified in the MVPA with MTL 
structures with enhanced spatial precision, mean time series 
were extracted from the unsmoothed data in native space for 
all manually delineated MTL structures. We compared FC 
between controls and patients (covariates: age, sex), correct-
ing at seed-level (p-corr) for multiple comparisons (online 
supplementary material S7).
4. Correlation with memory scores: To investigate whether re-
duced FC was associated with memory performance, correla-
tion analyses between these FC measures and memory scores 
were conducted across patients and corrected for multiple 
testing (p-corr). FC measures were residualised against age, 
sex, and seed ROI volume in order to ensure that memo-
ry impairment was associated with genuine dysconnectivity 
(and not weaker FC due to fewer voxels in the ROI).
resulTs
Clinical
Key results on autoantibodies and acute MRI findings are 
presented in table 1 (see online supplementary table S2 for a 
summary). LGI1 was the prominent autoantibody, and the 
remaining patients did not differ in their acute and post-acute 
presentation from those that tested positive for the LGI1 auto-
antibody (online supplementary material S8). The patients with 
ongoing seizures did not differ on clinical, neuropsychological 
or radiological measures from those that had been seizure-free 
for over a year (online supplementary material S9). Likewise, no 
differences were noted between the patients that had presented 
acutely with faciobrachial dystonic seizures from the rest (online 
supplementary material S10). No correlations were identified 
among memory composite scores, acute T2 MRI ratings, anti-
body titre, or delay to treatment (all ps, p>0.05).
neuropsychological assessment
Patients were impaired on visual and verbal recall and verbal 
recognition memory measures; visual recognition memory was 
intact (overall memory composite score: controls: mean (SD) 
0.74 (0.61); patients: mean (SD) −0.54 (0.83)). While patients 
scored higher than controls on the depression subscale of the 
Hospital Anxiety and Depression Scale, no participant scored 
in the severe range. Their performance on all other tests was 
no different from that of controls (table 2). Memory composite/
subcomposite scores did not correlate with premorbid Full-
Scale IQ (pFSIQ) or depression scores across patients (all rhos, 
rho|<0.28; p>0.21).
Volumetry
Patients showed bilateral hippocampal atrophy and reduced 
thalamic volumes. The rest of their volumes did not differ 
from control volumes (table 3). Hippocampal and thalamic 
volumes did not correlate with pFSIQ or depression (Hospital 
Anxiety and Depression Scale (HADS)) across patients (all rhos, 
rho|≤0.305; all ps, p≥0.167).
Total hippocampal volumes fell below 1.5 SDs from controls 
for 14/24 patients (figure 1B). Hippocampal and thalamic 
volume reduction were positively correlated. There was no 
thalamic atrophy (z<−1.5) in the absence of hippocampal 
atrophy (0/10 patients), whereas 9/14 patients with hippocampal 
atrophy showed non-atrophic thalamic volumes (z>−1.5), and 
all 5/5 patients with thalamic atrophy showed hippocampal 
atrophy (figure 1C).
Relationships with memory scores
However, composite memory scores did not correlate with 
patients’ hippocampal or thalamic volumes (table 3; S3), and 
did not differ among patients with bilateral (n=9), unilateral 
(n=5) or no hippocampal atrophy (n=10) (Kruskal-Wallis test: 
H=0.004, p>0.99).
Whole-brain voxel-based morphometry
Patients showed bilateral volume reduction in the hippocampal 
heads and bodies, the mediodorsal thalamus, and the posterior 
cingulate-precuneus (figure 1D; table 4). Patients’ pFSIQ and 
depression (HADS) scores did not correlate with these volumes 
(all rhos, rho|≤0.322; all ps, p≥0.143). Hippocampal and 
thalamic volumes were strongly correlated.
Relationships with memory scores
Nevertheless, volumes did not correlate with the overall 
composite memory scores, irrespective of smoothing or 
FWE-correction levels (table 4). Correlations were only found at 
uncorrected levels between verbal recall memory scores and GM 
volume of the left hippocampal clusters (all rs, 0.42<r < 0.45; 
all ps, 0.025<p<0.040; Online supplementary table S4).
Functional connectivity analysis
We subsequently examined FC abnormalities across the whole 
brain (MVPA). Patients differed from controls in the FC of the 
right hippocampus (figure 2A). In order to identify the regions 
with which the right hippocampus showed abnormal FC, as well as 
to avoid the possibility that the right hippocampal cluster disclosed 
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Table 2 Patients’ neuropsychological profile
domain Test subtest (measure)
Controls Patients
Controls vs patients
Test value p-corr
Impaired
Median IQr Median IQr criterion n
Episodic
memory
Verbal
recall
WMs-III logical memory 
immediate recall (z)
0.33 1.75 −0.84 1.33 t 4.97 <0.001 ≤−1.67 5
logical memory 
delayed recall (z)
0.67‡ 1.75 −0.84 2.25 u 98.00 <0.001 ≤−1.67 11
Word list immediate 
recall (z)
0.67 2.00 −0.67 0.92 t 5.58 <0.001 ≤−1.67 4
Word list delayed 
recall (z)
1.33‡ 1.00 −0.33‡ 2.00 u 158.50 <0.001 ≤−1.67 2
d&P People (z) −0.33 1.67 −1.33 1.09 t 3.49 0.026 ≤−1.67 7
Visual
recall
rOCFT Immediate recall (z) 1.32‡ 1.82 0.00 2.97 u 215.50 0.018 ≤−1.67 7
delayed recall (z) 1.38‡ 1.87 0.00 ‡ 3.42 u 220.50 0.034 ≤−1.67 8
D&P Shapes (z) 0.67 1.00 0.00 1.75 Wt 3.09 0.088 ≤−1.67 10
Verbal
recognition
WMs-III Word list recognition 
(z)
0.67‡ 1.00 0.00 ‡ 1.58 u 193.50 0.003 ≤−1.67 4
rMT Words (z) 1.00‡ 1.67 0.33 ‡ 1.67 u 241.50 0.046 ≤−1.67 3
d&P names (z) 0.33 2.00 −0.67 1.66 t 3.21 0.046 ≤−1.67 4
Visual
recognition
RMT Scenes (z) 1.00 1.01 0.59‡ 1.96 U 247.00 0.572 ≤−1.67 1
D&P Doors (z) 0.67 1.33 −0.17 1.75 t 1.89 0.768 ≤−1.67 7
RMT Faces (z) −0.33 2.66 −0.33 1.66 t 0.61 >0.999 ≤−1.67 4
Executive
function
WMS-III Digit span (z) 1.00 1.00 0.17 1.59 t 2.89 0.108 ≤−1.67 1
DKEFS Fluency Letter fluency (z) 1.33 1.17 0.00 1.66 t 2.64 0.203 ≤−1.67 1
Letter vs category 
fluency (z)
0.33 1.33 1.00 1.00 t −2.13 0.564 ≤−1.67 0
Category switching vs 
fluency (z)
0.00 1.67 0.33 1.00 t −1.83 0.768 ≤−1.67 0
DKEFS Trails Number and letter 
sequencing (z)
1.00‡ 0.66 0.00 1.41 U 242.50 0.088 ≤−1.67 0
Letter-number switching 
vs number and letter 
sequencing (z)
−0.33 0.67 −0.17 1.42 Wt −0.39 >0.999 ≤−1.67 1
Intelligence,
semantic memory, and 
language
WASI/WASI-II Vocabulary (z) 1.50 1.30 0.80 1.30 t 2.55 0.234 ≤−1.67 0
WASI/WASI-II Similarities (z) 0.95‡ 0.80 0.85 1.55 U 238.50 0.768 ≤−1.67 0
NART p-FSIQ (z) 1.44‡ 0.68 1.04‡ 0.71 U 260.00 0.245 ≤−1.67 0
GNT (z) 0.88 ‡ 0.98 0.15 1.91 U 295.50 0.693 ≤−1.67 3
C&CT (z) 0.34 1.30 0.02‡ 1.30 U 324.50 0.831 ≤−1.67 4
Mood and anxiety hAds depression (raw score; 
max=21)
1.00‡ 1.00 3.00‡ 4.50 u 182.00 0.008 ≥15 * 0
Anxiety (raw score; 
max=21)
3.50‡ 4.00 5.00 7.00 U 253.00 0.311 ≥15 * 1
Visuospatial and motor 
function
DKEFS Trails Visual scanning (z) 0.67‡ 1.67 0.00 1.34 U 359.50 >0.999 ≤−1.67 3
Motor speed (z) 0.67‡ 1.00 0.33‡ 0.67 U 367.50 >0.999 ≤−1.67 3
VOSP Cube analysis (raw 
score; max=10)
10.00‡ 1.00 10.00‡ 1.00 U 354.00 >0.999 ≤6† 2
Dot counting (raw score; 
max=10)
10.00‡ 0.00 10.00‡ 0.00 U 378.50 >0.999 ≤8† 0
Position discrimination 
(raw score; max=20)
20.00‡ 0.00 20.00‡ 1.00 U 387.00 >0.999 ≤18† 4
ROCFT Copy (ranked percentile 
ranges)
> 16th 
percentile‡
– > 16th 
percentile‡
– U 421.50 >0.999 ≤16th 
percentile
2
Controls (n = 39; 26M:13F; age: mean (SD) 60.86 (11.61) years) and patients (n = 24; 20M:4F; age: mean (SD) 63.45 (11.27) years) did not differ in age at assessment (t =−0.87, 
p=0.39) or M:F ratio (χ2 = 2.10, p=0.15).
*Cut-off score for severe range.
†5% cut-off score; ‘impaired’: number of patients below the cut-off score per test.
‡Shapiro-Wilk test: p<0.05.
Bold, p-corr <0.05; C&CT, Camel and Cactus Test; DKEFS, Dellis-Kaplan Executive Function System; D&P, Doors and People Test; GNT, Graded Naming Test; HADS, Hospital Anxiety 
and Depression Scale; NART, National Adult Reading Test; RMT, Recognition Memory Test; ROCFT, Rey-Osterrieth Complex Figure Test; U, Mann-Whitney U; VOSP, Visual Object 
and Space Perception Battery; WASI/WASI-II, Wechsler Abbreviated Scale of Intelligence; WMS-III, Wechsler Memory Scale III; Wt, Welch’s t-test; pFSIQ, premorbid Full-Scale IQ; 
p-corr, p values adjusted for Holm-Bonferroni sequential correction for multiple comparisons across all tests; t, Student’s t-test; z, age-scaled standardised scores.
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Table 3 Volumetry of medial temporal lobe and subcortical structures
structure hemisphere Mean (z) sd (z)
vs 0
n atrophic
Correlation with memory composite score
t p-corr r p-corr
HPC head r −1.71 1.79 −4.68 0.003 14 −0.035 >0.999
l −1.71 1.52 −5.53 0.0003 16 0.181 >0.999
body r −0.95 1.07 −4.37 0.006 7 0.043 >0.999
L −0.81 1.47 −2.69 0.25 8 n/a
Tail R −0.67 1.56 −2.11 0.83 9
L −0.58 1.51 −1.87 >0.999 7
ERC R −0.70 1.08 −3.18 0.09 3
L −0.77 1.35 −2.81 0.21 8
PRC R −0.43 1.25 −1.66 >0.999 1
L −0.21 1.13 −0.90 >0.999 2
PHC R −0.50 0.89 −2.76 0.23 2
L −0.36 1.20 −1.46 >0.999 5
AMG R 0.06 1.36 0.21 >0.999 3
L −0.14 1.72 −0.39 >0.999 4
TPC R 0.20 1.13 0.87 >0.999 1
L 0.30 1.01 1.46 >0.999 0
Thalamus r −0.75 0.95 −3.86 0.02 5 0.187 >0.999
l −0.89 1.04 −4.20 0.008 6 0.173 >0.999
Caudate nucleus R −0.03 1.00 −0.14 >0.999 1 n/a
L −0.02 1.36 −0.06 >0.999 2
Nucleus accumbens R −0.16 0.87 −0.88 >0.999 1
L −0.40 1.30 −1.51 >0.999 4
Pallidum R −0.28 1.10 −1.25 >0.999 3
L −0.22 1.32 −0.81 >0.999 3
Putamen R −0.23 1.10 −1.01 >0.999 3
L −0.38 0.94 −2.00 0.98 3
Brainstem −0.33 1.08 −1.49 >0.999 3
For controls and patients, MTL structures (hippocampal head, body, tail, amygdala, entorhinal, parahippocampal, perirhinal, temporopolar cortex) were manually segmented,and 
other subcortical structures (thalamus, pallidum, putamen, brainstem, nucleus accumbens, and caudate nucleus) were automatically segmented (FSL FIRST). All volumes were 
TIV-corrected and expressed as z-scores, based on the mean and SD of patients’ individually age-matched controls (± 10 years of age). Comparisons are hence conducted as one-
sample t-tests versus 0 (control mean); p-corr: two-tailed, adjusted with Holm-Bonferroni sequential correction for multiple testing. Bold: p-corr <0.05; r: Pearson’s correlation 
coefficient; of the volumes that showed reduction in patients relative to controls, none showed correlation with composite memory scores. No correlation was found with total/
left/right hippocampal atrophy at uncorrected levels (all ps, p>0.88); ‘n atrophic’: number of patients whose volumes fall below −1.5 SD from those of their age-matched healthy 
controls.
AMG, amygdala; ERC, entorhinal cortex; HPC, hippocampus; MTL, medial temporal lobe; PHC, parahippocampal cortex; PRC, perirhinal cortex; TIV, total intracranial volume; TPC, 
temporopolar cortex.
above resulted from suboptimal spatial coregistration of patients’ 
functional data to their atrophic hippocampi, we conducted a 
whole-brain seed-to-voxel FC analysis, seeding from the right 
hippocampus in native space (unsmoothed time series). Patients 
showed reduced FC with the medial prefrontal and posterome-
dial cortices (posterior cingulate-retrosplenial cortex-precuneus), 
extending to the left hippocampal tail (figure 2B–D). We further 
investigated reduced FC within the MTL to enhance spatial spec-
ificity (ROIs in native space, unsmoothed time series). Patients 
showed reduced FC between the right hippocampus and the 
left hippocampus, the right parahippocampal cortex and the left 
temporopolar cortex, and also between the right parahippocampal 
and left perirhinal cortices (figure 3A).
Relationships with memory scores
Patients’ weaker inter-hippocampal FC correlated with 
their lower overall composite memory scores (r=0.582, 
p-corr=0.025), with all three composite subscores showing 
this correlation (visual recall: r=0.444, p=0.039; verbal recall: 
r=0.482, p=0.020; verbal recognition: r=0.574, p=0.004). 
Posteromedial cortico-hippocampal FC also correlated with 
patients’ memory scores (overall: r=0.553, p-corr=0.037; 
visual recall: r=0.547, p=0.008; verbal recall: r=0.444, 
p=0.034; verbal recognition: r=0.477, p=0.021) (figures 2E 
and 3C). Inter-hippocampal and posteromedial cortico-hippo-
campal FC did not correlate with pFSIQ or depression scores 
(HADS) across patients (all rhos, rho|<0.010; all ps, p>0.700), 
and did not differ among patients with bilateral, unilateral, or no 
hippocampal atrophy (both Hs, H<3.300; both ps, p>0.190). 
Posteromedial cortico-hippocampal FC did not correlate with 
volume reduction in the same region (r=−0.20, p=0.36). 
Inter-hippocampal FC declined as a function of thalamic 
atrophy over and above hippocampal atrophy (r=0.500, 
p-corr=0.018), and as a function of the delay between symptom 
onset and recruitment to the study (r=-0.531, p-corr=0.018; 
figure 3D,E). In a series of exploratory multiple stepwise linear 
regression analyses (independent variables: structural, func-
tional abnormalities), reduced hippocampal FC measures were 
found to be the only predictors of memory impairment (online 
supplementary table S5).
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Table 4 Whole-brain voxel-based morphometry (grey matter volume)
smoothing (FWhM) FWe-correction level
Peak Cluster
Correlations
Memory scores
GM volumest x (mm) y (mm)
z
(mm) ke (nvox) structure r p-corr
4 mm Peak 5.90 −25 −16 −22 197 L HPC head 0.37 0.225 L HPC head – R body: r=0.61, p-corr=0.002
L – R HPC head: r=0.64, p-corr=0.002
R HPC head – body: r=0.82, p-corr<0.0001
5.75 37 −27 −11 36 R HPC body 0.10 0.986
5.57 31 −13 −17 61 R HPC head 0.15 0.986
Cluster size 5.90 −25 −16 −22 2156 L HPC head/body 0.32 0.424 R-L HPC: r=0.64, p-corr=0.005
R HPC – R Thal: r=0.54, p-corr=0.035
Rest of p-corr>0.15
5.75 37 −27 −11 2721 R HPC head/body 0.03 >0.999
5.22 19 −28 5 3085 R Thal 0.34 0.424
4.74 -2 −39 40 2086 L/R PCC/PrCu −0.02 >0.999
8 mm Peak 5.38 32 −15 −16 592 R HPC head/body 0.35 0.267 R-L HPC: r=0.65, p-corr=0.0006
R HPC – R Thal: r=0.55, p-corr=0.006
L HPC – R Thal: r=0.46, p-corr=0.02
5.19 −27 −15 −20 200 L HPC head/body 0.11 0.599
4.91 6 −12 7 179 R MD Thal 0.36 0.267
Cluster size 5.38 32 −15 −16 12 710 L/R HPC/Thal 0.31 0.294 r=0.32, p-corr=0.13
4.16 -1 −38 38 6606 L/R PCC/PrCu −0.03 0.900
Contrast: controls > patients; nuisance covariates: age, sex, TIV; voxel dimensions: 1 mm3 ; individual voxel threshold: p<0.001. The average GM volume from each cluster was 
extracted from each participant, residualised against age, sex, and TIV, and entered in a bivariate correlation analysis with the memory composite score. No correlation was noted 
with the GM volume of any cluster; hippocampal volume reduction strongly correlated with thalamic volume reduction in patients; p-corr: p values of the bivariate correlations 
conducted are adjusted for multiple testing using the Holm-Bonferroni sequential correction method, separately for the number of clusters disclosed in each of the four separate 
VBM analyses conducted.
GM, grey matter; HPC, hippocampus; L/R, left/right; MD, mediodorsal; PCC, posterior cingulate cortex; PrCu, precuneus; TIV, total intracranial volume; Thal, thalamus; VBM, voxel-
based morphometry.
Figure 2 Resting-state functional connectivity (Fc) analyses (whole-
brain). (a) a whole-brain, voxel-to-voxel resting-state Fc analysis (MVpa) 
contrasting patients and controls demonstrated that the two groups 
differed in the Fc of the right hippocampus with the rest of the brain 
(cluster-level p-FWe=0.018; ke=128 vox; peak: 26, –16, −22). heat bar 
indicates F values. (B–D) Regions showing reduced Fc with patients’ right 
hippocampi (F contrast: controls <>patients; nuisance covariates: age, sex). 
(B) Medial prefrontal/paracingulate cortex (cluster-level p-FWe<0.001; 
ke=547 vox; peak: 10, 48, –6). (c) Left posterior cingulate cluster, 
extending to precuneus, thalamus, and hippocampal tail (cluster-level 
p-FWe=0.024, ke=109 vox; peak: –10, –40, 4). (D) Right precuneus-
posterior cingulate cluster (cluster-level p-FWe<0.001, ke=434 vox; peak: 
6, –48, 6); heat bar indicates T values. (a–D) clusters are displayed on 
sagittal sections of IcBM template in MNI space. (e) correlation between 
right hippocampal-precuneal (c) Fc (residualised for age, sex, and right 
hippocampal seed volume) with (age-scaled standardised) composite 
memory scores in patients, surviving correction for multiple testing for 
all correlations (rest of p-corr>0.459). FWe, family-wise error; hpc, 
hippocampus; MVpa, multivariate pattern analysis.
Figure 3 Resting-state functional connectivity (Fc) analyses (MTL). (a) 
ROI-to-ROI Fc analysis for MTL structures (BOLD time-series extracted from 
unsmoothed data in native space; contrast: patients <>controls; nuisance 
covariates: age, sex); orange and red lines indicate Fc values that survive 
holm-Bonferroni correction (p-corr<0.05) for multiple comparisons (R 
hpc – L hpc; R hpc – R phc; R hpc – L Tpc; R phc – L pRc). colour 
in squares: average Fc of each ROI with other ROIs. (B, c) Inter-hpc Fc 
correlated with (age-scaled standardised) memory composite scores in 
patients (residualised against age, sex, and total hpc seed volume), and 
survived correction for multiple testing for all correlations of Fc measures 
with memory scores (rest of p-corr>0.459). (D) Inter-hpc Fc correlated 
with thalamic volumes in patients (residualised against age, sex, and 
total hpc volume). (e) patients’ inter-hpc Fc (residualised for age, sex, 
and total hpc volume) declined as a function of time since symptom 
onset. (D, e) correlations survived correction for multiple testing for the 
two Fc measures that correlated with memory scores. aMG, amygdala; 
BOLD, blood oxygenation level dependent; eRc, entorhinal cortex; hpc, 
hippocampus; L/R: left/right hemisphere; MTL, medial temporal lobe; phc, 
parahippocampal cortex; pRc, perirhinal cortex; ROI, region of interest; Tpc, 
temporopolar cortex.
dIsCussIOn
We conducted a detailed investigation of neuropsycholog-
ical performance and structural and functional brain imaging 
following VGKCC-Ab-LE, in order to identify: (1) extra-hip-
pocampal structural damage; (2) reduced hippocampal FC; (3) 
the role of those in residual cognitive dysfunction following 
VGKCC-Ab-LE.
We identified bilateral hippocampal atrophy that was highly 
focal within the MTL, along with correlated volume reduction 
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in the mediodorsal thalamus and precuneus-posterior cingulate, 
which are connected with the hippocampus within the limbic 
network.12 21 Our cohort showed disrupted hippocampal FC 
within the MTL as well as with anterior and posterior medial 
cortical regions. Inter-hippocampal FC declined as a function 
of time from the acute stage of the illness and as a function 
of thalamic volume reduction above and beyond hippocampal 
atrophy. Neuropsychological testing revealed a pure amnesic 
syndrome. Importantly, it was the FC of residual hippocampal 
tissue, rather than volume, which correlated with patients’ 
memory performance.
Acute stage clinical features
Τhe predominant antigenic target was LGI1. The percentage of 
patients with hippocampal high T2 signal (83%) was in line with 
previous reports (71%22; 73%6; 78%3). The neuropathology 
underlying acute hippocampal signal change in VGKCC-Ab-LE 
is unknown. Interestingly, the acute diffusion profile in VGKCC-
Ab-LE starkly contrasted with that of clinically similar conditions 
(eg, herpes simplex encephalitis), where restricted, as opposed 
to facilitated, diffusion within the hippocampal formation23 is 
more commonly observed. This may relate to differences in the 
types of cerebral oedema, that is, vasogenic in VGKCC-Ab-LE 
versus cytotoxic oedema elsewhere.
VGKCC-Ab-le is associated with focal hippocampal damage 
and dysfunction
Capitalising on the strengths of manually segmented MTL 
structures and whole-brain VBM, we found bilateral (especially 
anterior) hippocampal atrophy that was highly focal within the 
MTL. Our findings are consistent with the well-recognised focal 
T2 signal abnormalities in the hippocampus in the acute phase,24 
and extend prior studies6 9 by documenting normal volumes of 
extra-hippocampal MTL and other subcortical structures. Since 
the VGKCC is found throughout the peripheral and central 
nervous systems,1 the reason for such anatomical specificity in 
VGKCC-Ab-LE pathology is unclear. High LGI1 density within 
the hippocampus25 or local blood-brain barrier vulnerability 
may play a role.26 Nevertheless, the relatively focal nature of 
this disease supports its use as a lesion model for exploring the 
cognitive role of the hippocampus.27
VGKCC-Ab-le-related hippocampal atrophy is associated with 
thalamic volume reduction
The finding of bilateral volume reduction in the thalamus and 
the precuneus-posterior cingulate cortex in VGKCC-Ab-LE 
is novel and deserves further investigation. Several facts point 
towards the interpretation of such reduction as resulting from 
Wallerian degeneration through an extended limbic circuit12 21: 
(1) no thalamic or neocortical abnormality was observed in the 
acute clinical MRI; (2) volume reduction in the thalamus was 
strongly correlated with that in the hippocampus, and there was 
no thalamic atrophy in the absence of hippocampal atrophy; (3) 
animal models provide mechanistic reasons why the focus of 
acute pathology in LGI1 LE patients might be constrained to the 
MTL,28 suggesting that changes elsewhere may be consequent 
to MTL damage, rather than to antibodies per se; (4) thalamic 
abnormalities have been observed in other studies of human 
hippocampal damage— volume reduction in the thalamus has 
been noted in developmental amnesia, where hippocampal 
atrophy is held to occur focally within the MTL,29 and also in 
the limbic network following fornix damage30; (5) the concom-
itant volume reduction in the posteromedial cortex dovetails 
with the idea of network-specific degeneration across the hippo-
campal-diencephalic-cingulate circuitry,21 rather than with more 
widespread, autoantibody-driven pathology.
VGKCC-Ab-le causes focal amnesia with spared visual 
recognition memory
Our patients demonstrated amnesia with no deficits in other 
domains, in contrast to other reports (eg, Heine et al7). This 
is consistent with findings that VGKCC-Ab-LE patients often 
make substantial recovery post-immunotherapy in executive 
function, yet present with residual amnesia.5 The focal nature of 
our patients’ impairment is of importance in the interpretation 
of their brain abnormalities.
Patients showed striking preservation of visual recognition 
memory despite profound impairment of verbal and non-verbal 
recall and verbal recognition memory. There is a long-standing 
debate about whether recall and recognition memory rely on 
dissociable neurocognitive processes.30 31 One view is that asso-
ciative processes critical for recollection are dependent on the 
hippocampus, whereas familiarity is driven by non-hippocampal 
regions, particularly the perirhinal cortex.32 Accordingly, hippo-
campal atrophy should impair recollection but spare familiarity 
and (partly) recognition memory.33 Our finding that visual 
recognition memory is spared in patients with focal hippocampal 
damage and intact perirhinal cortex partly supports this view. 
However, we found impairment in all tests of verbal recognition. 
This is consistent with the idea that spared familiarity processes 
play a greater role in recognition memory for novel visual stimuli 
(eg, faces, doors), than they do for previously encountered, 
semantically laden stimuli (eg, words).34 Finer-grained tasks are 
necessary to explore these findings in detail and further charac-
terise the behavioural phenotype of autoimmune LE.
network dysfunction rather than focal atrophy predicts 
memory performance
Ever since the first description of patient H.M. 60 years ago,35 
it has been recognised that hippocampal damage, as occurs in 
conditions such as Alzheimer’s disease, temporal lobe epilepsy 
and LE, may result in focal amnesia. However, little is known 
about reduced FC that may be triggered by late-onset hippo-
campal damage, and its impact on memory performance.
Indeed, we found that it was the FC, and not the volume of the 
hippocampus, that predicted patients’ memory outcome. Our 
findings do not contradict the well-established role of the hippo-
campus in memory. Instead, they highlight the significance of an 
underappreciated aspect of hippocampal damage in explaining 
hippocampal amnesia, namely, the abnormal FC of residual 
hippocampal tissue with broader memory networks. Argu-
ably, haemodynamic properties of residual hippocampal tissue 
may reflect more accurately the extent to which the damaged 
hippocampus can interact with broader networks in supporting 
memory processes than hippocampal volumes derived from 
structural MRI.
In particular, memory impairment was associated with reduced 
posteromedial cortico-hippocampal and inter-hippocampal FC. 
The latter declined as a function of time from symptom onset. 
Inter-hippocampal FC has been linked to memory performance 
in young adults36 and patients with traumatic brain injury.37 It 
has also been reported to decline from healthy controls to mild 
cognitive impairment and even more so in Alzheimer’s disease,38 
and may reflect the integrity of the dorsal hippocampal commis-
sure.39 The fact that patients’ reduced (primarily mediodorsal) 
thalamic volumes positively correlated with this FC dovetails 
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with evidence supporting a complex interplay between midline 
thalamic nuclei and the hippocampus in mnemonic processes.40 
The relationship of amnesia with reduced posteromedial corti-
co-hippocampal FC is consistent with the well-established role 
of these cortical regions within the default-mode network.13 This 
network supports episodic memory processes, and its disruption 
is well-documented in episodic memory impairment (eg, Finke 
et al, Buckner et al,14 15).
limitations and future directions
We acknowledge a number of limitations and future directions 
that should be taken. Sample size was limited by the rarity 
of the condition, and larger cohorts may reveal more subtle 
brain-behaviour relationships. Furthermore, our study did 
not include disease controls, so we are unable to comment on 
whether our findings generalise to other types of LE. The 3T 
field strength prevented us from identifying subfield-specific 
atrophy, as reported elsewhere.9 Moreover, we observed no 
relationship among acute hippocampal abnormalities, delay to 
treatment, time since the acute stage of the illness, acute-stage 
antibody titres, and post-treatment memory outcome. Previous 
studies that have examined indicators of cognitive prognosis in 
VGKCC-Ab-LE show mixed results (Irani et al, Finke et al1 6 vs 
Malter et al, Miller et al8 9). There are many possible reasons 
for this inconsistency (variability in clinical presentation, types 
of immunotherapy, cognitive measures employed, statistical 
power). This question should be answered by large, prospec-
tive, multicentre studies. Finally, our cross-sectional approach 
prevented us from examining the time-course of extra-MTL 
abnormalities. The question of whether Wallerian degenera-
tion underlies neuronal loss through wider memory networks 
following hippocampal damage should be addressed with longi-
tudinal analyses.
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